The only destination for North American patient centricity leaders Patient experiences are too often long, lonely, confusing, and financially troubling. It is easy for mistrust to build between pharma and patients, causing a decline in adherence, trial participation and health outcomes across all patient groups, especially underserved communities. It is time for pharma to revolutionize the patient experience. So where do we begin? Step one, map the patient experience and identify new partners that will help you uncover engagement gaps. Step two, deep-dive personalized insights direct …